CORINNE SHAMEHDI: Open Payments
NPI 1063844199 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 14 payments from 8 companies in 2025. Trend: 2023 $1,027 · 2024 $1,659 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 4 | $341 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $261 |
| Novartis Pharmaceuticals Corporation | 2 | $154 |
| Legend Biotech USA Inc. | 2 | $73 |
| Celgene Corporation | 1 | $30 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
Products named: ZYNLONTA, Yescarta, SCEMBLIX, CARVYKTI, Fabhalta, BREYANZI, BRUKINSA, REVUFORJ.
Industry payments across FL — which companies pay providers there.
